banner

Norfolk Southern Orders PbC Batteries for Locomotive Switcher from Axion Power

Axion Power International (AXPW)

Axion Power International Inc. (OTCBB: AXPW), the developer of advanced lead­carbon PbC® batteries and energy storage systems, announced that it has received an order from Norfolk Southern Corp. (NYSE: FSC) for PbC batteries for use in a battery-powered locomotive.  Axion said this first $400,000 purchase order is part of a $475,000 total purchase order to be shipped and deployed over the next three to four months that will be used in the commissioning of Norfolk Southern’s NS-999.  To date, this is the largest single PbC battery order that Axion has received. No further details were disclosed.

“We have been working with Norfolk Southern for two and a half years, and we are very pleased that this first hybrid ‘switcher’ yard locomotive, to be run completely on PbC batteries, will soon be in service,” said Axion Power Chairman & CEO Thomas Granville.



A yard switcher locomotive is used in a train yard to assemble and disassemble long trip over-the-road trains as well as for general movement of railroad cars around the rail yard.

According to the Axion chief, the companies are working together to deploy the first “over the road” locomotive powered by Axion batteries.  The larger unit will require approximately twice the number of 100-percent recyclable batteries as the yard switcher.

“High-performance PbC batteries are ideally suited for hybrid locomotive applications due to their high charge acceptance, fast charge and discharge capabilities (important in regenerative braking), and their inherent ability to equalize voltage when utilized in large string configurations,” explained Granville.

Shares of AXPW are holding an uptrend in 2012; closing 2011 at 27 cents before surging to 64 cents late in January.  Shares cooled from the highs, but are still holding support above a 37 cent support level with yesterday’s close at 43 cents.

Axion Power (AXPW) Stock Quote and News:







Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Dig-It Underground Stock Chart Analysis Video

Dig-It Underground Stock Chart Analysis Video(0)

A spike in volume and rise in share price has Dig-It Underground (Pink Sheets: DIGX) on the radar for more movement in the morning. A thinly-traded stock, volatility has been strong in the chart as the MACD trends upwards towards zero as the chart is making a bounce off the bottom. The Relative Strength Index

GelTech Receives First Order for FireIce from Turkey

GelTech Receives First Order for FireIce from Turkey(0)

GelTech Solutions, Inc. (OTCBB: GLTC) this morning reported receipt of the first order from Turkey through partner Nano Girisim Ltd. Sti.  Nano Girism Ltd. Sti., a distributor of industrial products based in Istanbul.  Nano Girisim intends to initially promote GelTech’s FireIce, a revolutionary water enhancing fire suppressant for use in fire extinguishers, as Turkish law

Lyris to Host Third Quarter Earnings Webcast

Lyris to Host Third Quarter Earnings Webcast(0)

Global digital marketing company Lyris, Inc. (OTCBB:LYRI) will report its operating results for the third quarter of fiscal 2012 on Thursday, May 10. The company will hold a conference call and webcast to discuss its financial results and operating activities open to all interested parties at 8 a.m., Pacific Daylight Time (11 a.m., Eastern Daylight

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers(0)

Graft versus Host Disease (GvHD) is an area of great unmet medical that represents a significant risk to cancer patients throughout the world.  The condition occurs when patients receive a bone marrow transplant following radiation and/or chemotherapy, and the transplanted immune cells begin to attack the patient, causing significant pain and disability, or even death.

Judge Denies Taylor Armstrong’s Request to Dismiss Case with MyMedicalRecords.com, Damages Could Grow in Excess of $3 Million

Judge Denies Taylor Armstrong’s Request to Dismiss Case with MyMedicalRecords.com, Damages Could Grow in Excess of $3 Million(0)

In the latest round of the litigation between MMRGlobal, Inc. (OTCBB: MMRF) company MyMedicalRecords.com (“MMR”) and Beverly Hills Housewife Taylor Armstrong, Los Angeles Superior Court Judge Frederick Shaller dealt a blow to Taylor Armstrong in denying her motion for a summary judgment to have the MyMedicalRecords.com lawsuit against her dismissed. We first broke the story

read more
banner

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.